Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00259857 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 22
- Enrollment target
NCT00259857 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 22 participants.
The verdict
NCT00259857, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 22 participants
- Enrollment target
Study Summary
We have previously evaluated the safety and efficacy of Alendronate in 10 patients with juvenile osteoporosis during a 12-month clinical trial. We have documented that Alendronate improved BMD of the spine and hip without any major side effects. There were no additional fractures during therapy. The present study is designed to further evaluate the safety and efficacy of Alendronate in 20 children with juvenile osteoporosis using a double-blind, randomized, placebo-controlled, cross-over protocol.
Interventions
- DRUG Alendronate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2003-10 |
| Est. Completion | 2009-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00259857
The ClinicalTrials.gov registry entry for NCT00259857 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alendronate is the first listed.
NCT00259857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00259857 about?
NCT00259857 is a clinical study titled "Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis". We have previously evaluated the safety and efficacy of Alendronate in 10 patients with juvenile osteoporosis during a 12-month clinical trial. We have documented that Alendronate improved BMD of the spine and hip without any major side effects. There were no additional fractures during therapy. The...
What is the current status of trial NCT00259857?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2003-10. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00259857?
The interventions under investigation include: Alendronate (DRUG).
Who is sponsoring clinical trial NCT00259857?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.